What is the current Absorbable Hemostatic Powder market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Absorbable Hemostatic Powder market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Absorbable Hemostatic Powder market?

Increasing surgical procedures and demand for effective hemostasis solutions drive the market.

What challenges does the Absorbable Hemostatic Powder market face?

Stringent regulatory requirements and high production costs are significant challenges.

Which regions lead the Absorbable Hemostatic Powder market?

North America and Europe are the leading regions due to advanced healthcare infrastructure.

Who are the top companies in the Absorbable Hemostatic Powder market?

Key players include Johnson & Johnson, Baxter International, and Medtronic plc.

What future opportunities exist in the Absorbable Hemostatic Powder market?

Emerging economies and innovative product developments offer significant future outlook.

How does technology impact the Absorbable Hemostatic Powder market?

Advances in nanotechnology and biomaterials improve product efficacy and safety.

What is the regulatory landscape for the Absorbable Hemostatic Powder market?

Regulatory bodies like FDA and CE ensure compliance with strict safety and quality standards.

What is the future outlook for the Absorbable Hemostatic Powder market size?

The market is expected to reach USD 2.5 billion by 2033, driven by increasing demand.

Absorbable Hemostatic Powder Industry Size, Share & Growth Forecast 2033

Absorbable Hemostatic Powder by Application (Hospital, Clinics, Other), by Types (Gelatins, Polysaccharides, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $1250 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $1250 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Absorbable Hemostatic Powder Market Size | CAGR 8.2 Forecast 2033

Absorbable Hemostatic Powder Industry Size, Share & Growth Forecast 2033

🏭 Healthcare🌍 Global

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $1250 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $1250 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Absorbable Hemostatic Powder Market Overview

The Absorbable Hemostatic Powder market is a crucial segment in the medical industry, playing a vital role in wound care and surgical procedures. As the global population ages and the prevalence of chronic diseases increases, the Absorbable Hemostatic Powder market size is expected to witness significant growth, with a projected market size of approximately $1.2 billion by 2026. The growth outlook for the Absorbable Hemostatic Powder market forecast appears promising, driven by factors such as the increasing demand for minimally invasive surgeries and the rising adoption of advanced wound care products. The market forecast suggests a compound annual growth rate (CAGR) of around 8%, driven by macro drivers such as technological advancements, regulatory approvals, and changing consumer behavior. Key forces shaping the industry include technology shifts towards nanotechnology and biotechnology, stringent regulations, and intense competition among market players.

Loading chart…

The largest region in the Absorbable Hemostatic Powder market is North America, accounting for a significant share of the global market. The fastest-growing region, however, is expected to be Asia-Pacific, driven by the increasing demand for advanced wound care products and the growing presence of key market players. The Absorbable Hemostatic Powder market is expected to witness significant industry expansion, driven by technological advancements, regulatory approvals, and changing consumer behavior. As the market continues to evolve, key players are expected to focus on developing innovative products, expanding their distribution networks, and strengthening their presence in emerging markets.

Report Overview

Report Attribute	Details
Market size value in 2025	1.25 billion
Revenue forecast in 2033	2.35 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Curasan AG; Johnson & Johnson Services, Inc.; BD; Baxter; GELITA MEDICAL; Aegis Lifesciences; Hemostasis, LLC; Success Bio-Tech; Biotemed; Zhonghuishengxi Bioengineering; Aitekang Medical Technology; Betatech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Absorbable Hemostatic Powder market is poised for significant growth, driven by increasing demand for effective hemostasis solutions. The market dynamics are shaped by various factors, including technological advancements, regulatory requirements, and shifting consumer preferences.

Growth Drivers2 items

Advances in biotechnology and biomaterials have led to the development of innovative absorbable hemostatic powders with improved efficacy and safety profiles, driving the growth of the Absorbable Hemostatic Powder market size.

The increasing prevalence of surgical procedures and trauma cases has created a high demand for effective hemostatic agents, contributing to the growth forecast of the Absorbable Hemostatic Powder market.

Restraints2 items

Stringent regulatory requirements and quality standards for absorbable hemostatic powders can limit the entry of new players in the market, potentially hindering the growth of the Absorbable Hemostatic Powder market size.

The high cost of development and production of absorbable hemostatic powders can make them less competitive than traditional hemostatic agents, affecting the overall growth forecast of the Absorbable Hemostatic Powder market.

Opportunities2 items

The increasing adoption of minimally invasive surgical procedures has created opportunities for the development of absorbable hemostatic powders that can be used in these procedures, driving the growth of the Absorbable Hemostatic Powder market.

The growing demand for biodegradable and biocompatible hemostatic agents has led to the development of new absorbable hemostatic powders, contributing to the expansion of the Absorbable Hemostatic Powder market size.

Challenges2 items

The Absorbable Hemostatic Powder market faces challenges related to scalability and manufacturing efficiency, which can impact the production costs and availability of these products, affecting the growth forecast of the market.

The need for standardization and harmonization of regulatory requirements across different regions can be a significant challenge for companies operating in the global Absorbable Hemostatic Powder market, influencing the overall market size.

Market Segmentation

Loading chart…

The Application segment of the Absorbable Hemostatic Powder market is divided into various subtypes, including surgical procedures and wound care. This segmentation contributes to the overall market size by highlighting the specific use cases where Absorbable Hemostatic Powder is most effective. Understanding the application segmentation is crucial for industry players to develop targeted products and marketing strategies, ultimately driving growth in the Absorbable Hemostatic Powder market. The Absorbable Hemostatic Powder segmentation by application provides valuable insights into the market's dynamics and trends.

The Types segment of the Absorbable Hemostatic Powder market comprises subtypes such as [object Object] and [object Object]. This segmentation is essential in defining the product offerings and technological advancements in the market. By analyzing the types of Absorbable Hemostatic Powder, industry stakeholders can identify areas of innovation and opportunities for differentiation. The market taxonomy of Absorbable Hemostatic Powder types enables companies to develop products that cater to specific needs, ultimately contributing to the growth of the overall market. The types segment is a critical component of the Absorbable Hemostatic Powder market, and its analysis is vital for understanding the market's competitive landscape.

Absorbable Hemostatic Powder Segmentation Breakdown8 items

Application

Hospital

Clinics

Other

Types

Gelatins

Polysaccharides

Other

Regional Insights

Loading chart…

The Absorbable Hemostatic Powder market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 35% of the market share. The fastest-growing region is anticipated to be the Asia Pacific, driven by increasing adoption of advanced medical technologies and rising investments in healthcare infrastructure.

Key drivers for the North America region include policies supporting the development of innovative medical products, a mature ecosystem with established healthcare infrastructure, and a high demographics of patients requiring surgical procedures. In Europe, drivers include adoption of minimally invasive surgical techniques, investments in research and development, and a well-established regulatory framework. The Asia Pacific region is driven by infrastructural developments, rising demographics of the aging population, and increasing adoption of advanced medical technologies.

Latin America and the Middle East & Africa regions are expected to experience steady Absorbable Hemostatic Powder market growth, driven by investments in healthcare infrastructure, increasing adoption of advanced medical technologies, and rising demographics of patients requiring surgical procedures. The regional forecast indicates that these regions will play a crucial role in the overall market growth, with opportunities for ecosystem development and regulatory framework establishment.

Competitive Landscape

The Absorbable Hemostatic Powder market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Absorbable Hemostatic Powder competitive landscape is characterized by high competition, with companies focusing on differentiation through product portfolios and regional expansion. Key competitive levers include pricing strategies, partnerships, and product launches.

Companies in the market are adopting various strategies to stay competitive, including M&A, partnerships, and R&D investments. Competitive differentiation is achieved through technology, service models, and channel strength. However, companies face challenges such as margin pressure, compliance costs, and supply chain risks. To overcome these challenges, companies are focusing on strategic initiatives such as regional expansion, innovation pipelines, and localization.

Curasan AG: regional expansion

Johnson & Johnson Services, Inc.: premium pricing

BD: OEM tie-ups

Baxter: innovation pipeline

GELITA MEDICAL: local manufacturing

Aegis Lifesciences: vertical integration

Key Absorbable Hemostatic Powder Companies12 items

Curasan AG

Johnson & Johnson Services, Inc.

Baxter

GELITA MEDICAL

Aegis Lifesciences

Hemostasis, LLC

Success Bio-Tech

Biotemed

Zhonghuishengxi Bioengineering

Aitekang Medical Technology

Betatech

Market Ecosystem

The Absorbable Hemostatic Powder ecosystem encompasses a network of participants that collaborate to design, manufacture, and deliver absorbable hemostatic powders to end-users. The ecosystem can be broadly categorized into upstream, midstream, and downstream segments, comprising technology providers, suppliers, integrators, channels, and end-users. Value is created and captured through the development of innovative products, efficient manufacturing processes, and effective distribution channels.

Raw material suppliers — provide key ingredients

OEMs / manufacturers — produce absorbable hemostatic powders

Technology providers — develop underlying technologies

Distributors / channel partners — deliver products to end-users

Regulators/standards bodies — establish industry standards

Service providers / after-sales — offer support and maintenance

End users / buyers — purchase and utilize absorbable hemostatic powders

In the Absorbable Hemostatic Powder ecosystem, control points are largely influenced by regulatory bodies and end-users, who drive adoption through their purchasing decisions and feedback. Dependency risks arise from input constraints, such as the availability of raw materials, and standards approvals, which can impact production and distribution. Switching costs and partnerships are also crucial, as companies may need to adapt to new technologies or form alliances to remain competitive. Furthermore, the ecosystem may differ by region due to varying regulatory requirements and market demands, highlighting the need for a comprehensive value chain analysis to navigate these complexities.

Recent Industry Insights

The Absorbable Hemostatic Powder industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships have been formed between key players to enhance product offerings and expand market reach. Recent mergers and acquisitions have also led to increased consolidation in the industry, resulting in a more competitive landscape. Furthermore, several companies have launched innovative products and technologies, focusing on improved efficacy and reduced adverse effects. Regulatory changes have also played a crucial role in shaping the industry, with updates to guidelines and standards influencing the development and approval of absorbable hemostatic powders.

In addition to these developments, there has been a notable shift in consumer and enterprise trends, with a growing emphasis on minimally invasive procedures and sustainable medical practices. This shift has driven demand for absorbable hemostatic powders, leading to increased funding rounds and expansions for companies operating in this space. As the industry continues to evolve, it is likely that we will see further innovations and advancements in absorbable hemostatic powder technology, driving growth and transformation in the market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Absorbable Hemostatic Powder market outlook. The market exhibits high attractiveness due to its potential to revolutionize surgical procedures with minimal complications. The competitive intensity is moderate, with key players focusing on innovative products and strategic partnerships. The long-term outlook appears promising, driven by increasing demand for minimally invasive surgeries and advancements in biotechnology.

The innovation landscape is dynamic, with ongoing research into new materials and applications. However, the demand-supply balance may be affected by regulatory risks and supply chain disruptions. Key risk factors include stringent regulations and fluctuating raw material prices. Despite these challenges, the Absorbable Hemostatic Powder market is expected to experience steady growth, driven by its potential to improve patient outcomes and reduce healthcare costs.

11 items

1. Executive Summary

2. Absorbable Hemostatic Powder Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Absorbable Hemostatic Powder Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Absorbable Hemostatic Powder Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinics

6.1.3. Other

6.2. Global Absorbable Hemostatic Powder Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Gelatins

6.2.2. Polysaccharides

6.2.3. Other

6.3. Global Absorbable Hemostatic Powder Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Absorbable Hemostatic Powder Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Absorbable Hemostatic Powder Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Absorbable Hemostatic Powder Market Competition by Key Manufacturers

8.1. Global Absorbable Hemostatic Powder Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Absorbable Hemostatic Powder: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Curasan AG

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Johnson & Johnson Services, Inc.

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. BD

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Baxter

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. GELITA MEDICAL

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Aegis Lifesciences

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Hemostasis, LLC

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Success Bio-Tech

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Biotemed

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Zhonghuishengxi Bioengineering

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Aitekang Medical Technology

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Betatech

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Absorbable Hemostatic Powder Market

Figure 4: Global Absorbable Hemostatic Powder Market: Drivers

Figure 5: Global Absorbable Hemostatic Powder Market: Challenges

Figure 6: Global Absorbable Hemostatic Powder Market: Trends

Figure 7: Global Absorbable Hemostatic Powder Market: Opportunity

Figure 8: Global Absorbable Hemostatic Powder Market: Restraint

Figure 9: Global Absorbable Hemostatic Powder Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Absorbable Hemostatic Powder Market Value (USD Million) By Region

Figure 15: Global Absorbable Hemostatic Powder Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Absorbable Hemostatic Powder Market Value (USD Million) By Region

Figure 23: Global Absorbable Hemostatic Powder Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

77 items

Table 1: Market Segmentation Analysis

Table 2: Global Absorbable Hemostatic Powder Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Absorbable Hemostatic Powder Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Absorbable Hemostatic Powder Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Absorbable Hemostatic Powder Market Value (USD Million) By Region

Table 10: Global Absorbable Hemostatic Powder Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Absorbable Hemostatic Powder Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Absorbable Hemostatic Powder Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Absorbable Hemostatic Powder Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Curasan AG Basic Information And Sales Area

Table 31: Curasan AG. Products Portfolio

Table 32: Johnson & Johnson Services, Inc. Basic Information And Sales Area

Table 33: Johnson & Johnson Services, Inc.. Products Portfolio

Table 34: BD Basic Information And Sales Area

Table 35: BD. Products Portfolio

Table 36: Baxter Basic Information And Sales Area

Table 37: Baxter. Products Portfolio

Table 38: GELITA MEDICAL Basic Information And Sales Area

Table 39: GELITA MEDICAL. Products Portfolio

Table 40: Aegis Lifesciences Basic Information And Sales Area

Table 41: Aegis Lifesciences. Products Portfolio

Table 42: Hemostasis, LLC Basic Information And Sales Area

Table 43: Hemostasis, LLC. Products Portfolio

Table 44: Success Bio-Tech Basic Information And Sales Area

Table 45: Success Bio-Tech. Products Portfolio

Table 46: Biotemed Basic Information And Sales Area

Table 47: Biotemed. Products Portfolio

Table 48: Zhonghuishengxi Bioengineering Basic Information And Sales Area

Table 49: Zhonghuishengxi Bioengineering. Products Portfolio

Table 50: Aitekang Medical Technology Basic Information And Sales Area

Table 51: Aitekang Medical Technology. Products Portfolio

Table 52: Betatech Basic Information And Sales Area

Table 53: Betatech. Products Portfolio

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Market Value (USD Million) (2025-2032) By Types

Table 57: Global Market Share (%) By Types (2032)

Table 58: Global Absorbable Hemostatic Powder Market Value (USD Million) By Region

Table 59: Global Absorbable Hemostatic Powder Market Share (%) By Region (2025-2032)

Table 60: North America Market Value (USD Million) (2025-2032) By Country

Table 61: North America Market Value (USD Million) (2025-2032) By Application

Table 62: North America Market Value (USD Million) (2025-2032) By Types

Table 63: Europe Market Value (USD Million) (2025-2032) By Country

Table 64: Europe Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Types

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 69: South America Market Value (USD Million) (2025-2032) By Country

Table 70: South America Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Types

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 75: Research Programs/Design For This Report

Table 76: Key Data Information From Secondary Sources

Table 77: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Absorbable Hemostatic Powder Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.25 billion
Revenue forecast in 2033	2.35 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Curasan AG; Johnson & Johnson Services, Inc.; BD; Baxter; GELITA MEDICAL; Aegis Lifesciences; Hemostasis, LLC; Success Bio-Tech; Biotemed; Zhonghuishengxi Bioengineering; Aitekang Medical Technology; Betatech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options